Work

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117026

Authors: Luciano J Costa, Edward A. Stadtmauer, Gareth Morgan, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L Kaufman, Mehrdad Mobasher, Kevin J. Freise, Jeremy A. Ross, John Pesko, Wijith Munasinghe, Saketh Gudipati, Sarah Mudd, Orlando Bueno, Shaji K. Kumar

Institutions: University of Alabama at Birmingham, Abramson Cancer Center, University of Pennsylvania, University of Arkansas for Medical Sciences, University of Kentucky, University of Utah, Huntsman Cancer Institute, VA Puget Sound Health Care System, University of Chicago, Emory University, Winship Cancer Institute, Genentech, AbbVie (United States), Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4248377423

Cites:

Cited by: 18

Related to: 10